# A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy

> **NCT00209534** · PHASE2 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 200 (—)

## Conditions studied

- Colonoscopy
- Colon Polyps

## Interventions

- **DRUG:** fospropofol disodium

## Key facts

- **NCT ID:** NCT00209534
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** —
- **Final completion:** 2004-02
- **Target enrollment:** 200 (—)
- **Last updated:** 2009-12-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00209534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00209534, "A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00209534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*